Works matching IS 03407004 AND DT 2003 AND VI 52
Results: 97
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 739, doi. 10.1007/s00262-003-0405-8
- By:
- Publication type:
- Article
Naturally occurring B-cell responses to breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 715, doi. 10.1007/s00262-003-0409-4
- By:
- Publication type:
- Article
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 751, doi. 10.1007/s00262-003-0410-y
- By:
- Publication type:
- Article
Identification of new MHC-restriction elements for presentation of the p210<sup>BCR-ABL</sup> fusion region to human cytotoxic T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 761, doi. 10.1007/s00262-003-0415-6
- By:
- Publication type:
- Article
Natural CD8<sup>+</sup> T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 771, doi. 10.1007/s00262-003-0420-9
- By:
- Publication type:
- Article
Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 12, p. 780, doi. 10.1007/s00262-003-0421-8
- By:
- Publication type:
- Article
l-Ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8–independent pathway.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 693, doi. 10.1007/s00262-003-0407-6
- By:
- Publication type:
- Article
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 699, doi. 10.1007/s00262-003-0412-9
- By:
- Publication type:
- Article
Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 708, doi. 10.1007/s00262-003-0413-8
- By:
- Publication type:
- Article
Cellular immunity for cancer chemoimmunotherapy—an overview.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 661, doi. 10.1007/s00262-003-0423-6
- By:
- Publication type:
- Article
Modulation of costimulation to enhance tumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 663, doi. 10.1007/s00262-003-0424-5
- By:
- Publication type:
- Article
Tumor microvasculature as a barrier to antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 670, doi. 10.1007/s00262-003-0425-4
- By:
- Publication type:
- Article
On combining antineoplastic drugs with tumor vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 680, doi. 10.1007/s00262-003-0426-3
- By:
- Publication type:
- Article
Combinations of anticancer drugs and immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 11, p. 686, doi. 10.1007/s00262-003-0427-2
- By:
- Publication type:
- Article
Rapid turnover of the CD8<sup>+</sup>CD28<sup>-</sup> T-cell subset of effector cells in the circulation of patients with head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 599, doi. 10.1007/s00262-003-0395-6
- By:
- Publication type:
- Article
The effects of αGalCer-induced TCRVα24 Vβ11<sup>+</sup> natural killer T cells on NK cell cytotoxicity in umbilical cord blood.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 625, doi. 10.1007/s00262-003-0398-3
- By:
- Publication type:
- Article
A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 608, doi. 10.1007/s00262-003-0399-2
- By:
- Publication type:
- Article
Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 643, doi. 10.1007/s00262-003-0400-0
- By:
- Publication type:
- Article
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 638, doi. 10.1007/s00262-003-0402-y
- By:
- Publication type:
- Article
Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 592, doi. 10.1007/s00262-003-0404-9
- By:
- Publication type:
- Article
Lymphocyte subsets and T<sub>h</sub>1/T<sub>h</sub>2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 617, doi. 10.1007/s00262-003-0406-7
- By:
- Publication type:
- Article
Tumor mRNA–loaded dendritic cells elicit tumor-specific CD8<sup>+</sup> cytotoxic T cells in patients with malignant glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 632, doi. 10.1007/s00262-003-0408-5
- By:
- Publication type:
- Article
Optimizing dendritic cell–based anticancer immunotherapy: maturation state does have clinical impact.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 583, doi. 10.1007/s00262-003-0414-7
- By:
- Publication type:
- Article
Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 561, doi. 10.1007/s00262-003-0394-7
- By:
- Publication type:
- Article
Safety, biodistribution, pharmacokinetics, and immunogenicity of <sup>99m</sup>Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 576, doi. 10.1007/s00262-003-0396-5
- By:
- Publication type:
- Article
Development of Therapeutic Cancer Vaccines Conference, 27–29 April 2003.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 648, doi. 10.1007/s00262-003-0422-7
- By:
- Publication type:
- Article
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 535, doi. 10.1007/s00262-003-0383-x
- By:
- Publication type:
- Article
CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 546, doi. 10.1007/s00262-003-0392-9
- By:
- Publication type:
- Article
Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 555, doi. 10.1007/s00262-003-0393-8
- By:
- Publication type:
- Article
Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 10, p. 655, doi. 10.1007/s00262-003-0438-z
- By:
- Publication type:
- Article
NK cells in allogeneic bone marrow transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 525, doi. 10.1007/s00262-003-0378-7
- By:
- Publication type:
- Article
Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 9, p. 569, doi. 10.1007/s00262-003-0401-z
- By:
- Publication type:
- Article
In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RI.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 513, doi. 10.1007/s00262-002-0371-6
- By:
- Publication type:
- Article
Targeted cytotoxic effect of anti-JL1 immunotoxin against a human leukemic cell line and its clinical implications.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 506, doi. 10.1007/s00262-003-0374-y
- By:
- Publication type:
- Article
Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 497, doi. 10.1007/s00262-003-0377-8
- By:
- Publication type:
- Article
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 481, doi. 10.1007/s00262-003-0384-9
- By:
- Publication type:
- Article
Therapeutic effect of a single peritumoural dose of IL-2 on transplanted murine breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 487, doi. 10.1007/s00262-003-0385-8
- By:
- Publication type:
- Article
Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 8, p. 473, doi. 10.1007/s00262-003-0387-6
- By:
- Publication type:
- Article
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
- Published in:
- 2003
- By:
- Publication type:
- Erratum
Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 445, doi. 10.1007/s00262-002-0368-1
- By:
- Publication type:
- Article
Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 413, doi. 10.1007/s00262-003-0382-y
- By:
- Publication type:
- Article
Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 429, doi. 10.1007/s00262-003-0386-7
- By:
- Publication type:
- Article
Prognostic value of the CD4<sup>+</sup>/CD8<sup>+</sup> ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 423, doi. 10.1007/s00262-003-0388-5
- By:
- Publication type:
- Article
Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 455, doi. 10.1007/s00262-003-0389-4
- By:
- Publication type:
- Article
Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 438, doi. 10.1007/s00262-003-0390-y
- By:
- Publication type:
- Article
Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 463, doi. 10.1007/s00262-003-0391-x
- By:
- Publication type:
- Article
Editorial statement from Graham Pawelec.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 411, doi. 10.1007/s00262-003-0403-x
- By:
- Publication type:
- Article
Editorial statement from R.W. Baldwin.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 7, p. 409, doi. 10.1007/s00262-003-0411-x
- By:
- Publication type:
- Article
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 359, doi. 10.1007/s00262-002-0365-4
- By:
- Publication type:
- Article
International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.
- Published in:
- Cancer Immunology, Immunotherapy, 2003, v. 52, n. 6, p. 403, doi. 10.1007/s00262-002-0366-3
- By:
- Publication type:
- Article